Table 2.
Treatment completion and complete response rate
| MPV3 (n = 23) | MTX5 (n = 15) | Fisher’s test results | |
|---|---|---|---|
| MPV / MTX complete | 20 (87%) | 13 (87%) | |
| Ara-C complete | 18 (78%) | 13 (87%) | |
| CR / PR / SD / PD | 7 / 13 / 1 / 2 | 8 / 6 / 0 / 1 | |
| CR rate after chemotherapy | 30% | 53% | 0.2 |
| Response rate | 87% | 93% | |
| Whole brain radiotherapy | 18 (78%) | 7 (47%) | 0.2 |
| CR / PR / SD / PD | 13 / 10 / 0 / 0 | 14 / 1 / 0 / 0 | |
| CR rate after radiotherapy | 57% | (93%) | 0.03 |
| Response rate | 100% | 100% |
CR: complete response, MPV: methotrexate + procarbazine + vincristine, MTX: methotrexate, PD: progressive disease, PR: partial response, SD: stable disease.